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ABSTRACT
Myoplasties of the extraocular muscle may cause
adhesions between the operated muscle and the adjacent tissues,
commonly generating cicatricial strabismus. With the purpose
of reducing to a minimum the occurrence of adhesion, the
effects of mitomycin C, an antifibrotic agent, were studied in
concentrations of 0.008%, 0.02%, and 0.04% applied during
intraoperative of myoplasties of the superior rectus muscle of
rabbits. Fifty six animals were divided in five groups. During
the postoperative, the operated areas were washed with
physiological solution. Eye drop instillation to prevent
inflammation and bacterial infection were used. The method
to analyze the results consisted of clinical and histological
evaluation and statistical analyzes. We also evaluated at the
same time the amount of basic fibroblast growth factor (FGF-
2) by immunohistochemical study. Clinically, more adhesions
were found in the eyes of the control group than in the groups
of treated eyes. However there was no significant statistics
difference between the two groups (P>0.05). Histologically,
mitomycin C caused a delayed cicatrization in the mioplastic
areas, specially in the group who received the 0.02%
concentration. The immunohistochemical showed FGF-2
marking in fibroblasts and macrophages, but between the
groups there wasn’t no difference. Based on those results,
mitomycin C in the utilized concentrations was capable of
delaying the cicatrization and consequently avoid the secondary
strabismus without undesirable side effects.
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RESUMO
Mioplastias da musculatura extra-ocular podem
ensejar aderências entre o músculo operado e os tecidos
adjacentes, produzindo, não raro, estrabismos cicatriciais. Com
intuito de se minimizar a ocorrência de aderências,
investigaram-se os efeitos da mitomicina C, como agente
antifibrótico, em concentrações ascendentes de 0,008, 0,02 e
0,04%, aplicada no per-operatório de mioplastias do reto
superior do bulbo do olho de coelhos. Operaram-se 56 animais,
que compuseram cinco grupos. No pós-operatório, instituíram-
se limpeza com solução fisiológica das áreas operadas e
profilaxia antimicrobiana e antiinflamatória, na forma de
colírio. Avaliações clínica, histológica e imunoistoquímica,
em que se estudou o fator de crescimento fibroblástico-básico
(FGF-2), e estatística compuseram os métodos de análise dos
resultados. Encontraram-se, clinicamente, mais aderências nos
olhos-controle, comparativamente aos tratados, embora sem
diferença estatística (P>0,05). À histologia, verificou-se que a
mitomicina C ensejou retardo da cicatrização junto às áreas
das mioplastias, notadamente no grupo que a recebeu, à
concentração de 0,02%. A imunoistoquímica revelou marcação
do FGF-2 em fibroblastos e macrófagos indistintamente entre
os grupos. Com base nos resultados, permite-se admitir que a
mitomicina C, nas concentrações em que foi empregada,
retardou a cicatrização e, por conseguinte, o estrabismo
secundário, sem ensejar efeitos colaterais.
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INTRODUCTION
Myoplasties of extra ocular muscle may
cause adhesions between the operated muscle and the
adjacent tissues, allowing the occurrence of oculomotor
dysfunctions and cicatricial strabismus (CRUZ, 1996).
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To prevent them physical barriers have been tested
such as gelatinous sponge of animal skins, synthetic
polypeptides, polyglactin 910, viscoelastic substances,
capsules of Tenon and silicone (SILVA, 1983; ELSAS
et al., 1992; HWANG & CHANG, 1996). Furthermore
anticicatricial agents were also used such as
daunorubicin, bleomycin, mitramycin, 5-fluoracil,
cyanoacrylate and mitomycin C (LEE et al., 1990; CRUZ,
1996; MAMEDE et al., 2004).
Antifibrotic effects of mitomycin C have
been reported in in vitro and in vivo studies
(KUNITOMO & MORI, 1969; YAMAMOTO et al.,
1990). There have been several communications
regarding the use of antifibrotics effects in the
correction of strabismus in concentration varying from
0.02% to 0.05% (BROOKS et al., 1996; CRUZ, 1996; OH
et al., 1999; MINGUINI et al., 2000; MAHINDRAKAR
et al., 2001; MAMEDE et al., 2004). Those studies
evaluated the effects of mitomycin C after its utilization
on myoplasties, by contact between the substances
and the tissues in time periods varying from 1 to 5
minutes (BROOKS et al., 1996; CRUZ, 1996; OH et al.,
1999; MINGUINI et al., 2000; MAMEDE et al., 2004).
Despite the good results confirmed by many
researchers, there have been some controversies about
the efficacy of mitomycin C as an antifibrotic agent
(BROOKS et al., 1996; MINGUINI et al., 2000). Side
effects have been reported such as discomfort,
persistent photophobia, conjunctival hyperemia and
chemosis. Conjunctival granulomas, punctiform
keratitis, melting and perforation of the cornea, areas
of scleral calcifications, secondary glaucoma and
cataract have also been reported. (RUBINFELD et al.,
1992; ANDUZE & BURNETT, 1996; DOUGHERTY et
al., 1996; MAMEDE et al., 2004).
The present study aimed at investigating
the antifibrotic action of mitomycin C, applied during
the myoplastic of the dorsal rectus, in different
concentrations, based on the clinical, histological and
immunohistochemical studies.
MATERIAL   AND   METHODS
Prior to its performance the research project
was evaluated and approved by the ‘Chamber of Ethics
in Animal Research’ of the College of Agricultural and
Veterinarian Sciences, São Paulo University – UNESP -
Jaboticabal, São Paulo, Brazil. The rules of Association
for Research in Vision and Ophthalmology –ARVO
(National Institutes of Health Publications No. 85-23:
Revised 1985) and the Nüremberg Code (GOLDIM,
1995) were also complied with.
Fifty-six rabbits (Oryctolagus cuniculus,
LILLJEBORG, 1874) of the New Zealand race, adults,
males and females, weighing above 2kg were utilized.
They were divided in five categories: Negative Control
Group (NCG), Positive Control Group (PCG) and groups
subjected to treatment with mitomycin C in the
concentrations 0.008% (GT-1) 0.02% (GT-2) and 0.04%
(GT-3).
To minimize the effects of individual
variations and to increase the amount of samples, both
eyes of each animal were utilized excepting the animals
of the control group, NCG, which had only one of the
eyes operated. The dorsal rectus muscle was recessed
5 to 8 mm. In the NCG, 0.9% physiological solution was
instilled in the myoscleral suture for 5 minutes. And in
the PCG, after the recession, a 0.9% physiological
solution was instilled in the myoscleral suture for five
minutes, and in the contra-lateral eye the effects of
mitomycin C were evaluated. This group was study
considering the possibility of the mitomycin C affecting
the untreated eye by absorption and systemic
dissemination.
In the groups GT-1, GT-2 and GT-3 after the
recession of the dorsal rectus muscle, mitomycin C in
the concentration of 0.008%, 0.02% and 0.04% was
instilled on the myoscleral suture for five minutes.
To perform the surgical techniques the
rabbits were anesthetized with xilazina (5mg kg-1, IV)
(Virbaxyl 2% - Cloridrato de xilazina – Virbac – São Paulo,
SP, Brasil) and ketamina (25mg kg-1 IV) (Vetaset –
Cloridrato de Quetamina – Fort Dodge – Campinas, SP,
Brasil) and maintained in the anesthetic plan with
halothane (Fluothane - Halotano – AstraZeneca –
Cotia, SP, Brasil) in a semi open circuit (KOHN et al.,
1997). The employed surgical technique for the muscle
recession and myoplasties was the divulsion of the
bulbar conjunctiva from the corneosclera limbus
between 11 and 14 hours of a clock, identification and
isolation of the dorsal rectus muscle, resection close
to its scleral insertion and myoscleral suture with Vicryl
6-0 (Vicryl 6-0 (J544G)– Poliglactina 910 – Ethicon –
São José dos Campos, SP, Brasil) (Figure 1) (PARKS,
1983). Afterwards physiological solution or mitomycin
C in the different concentrations were applied on the
myoplastic areas. After the surgical procedures the area
was washed with physiological solution and the suture
of the capsule of Tenon and bulbar conjunctiva was
performed using Vicryl 6-0.
During the postoperative period the ocular
surface was submitted to daily rinsing and prophylactic
instillation of eye drops composed of neomycin,
polymyxin B and dexamethasone (Maxitrol – Sulfato
de Neomicina, Sulfato de Polimixina B e Dexametasona
– Alcon do Brasil – São Paulo, SP, Brasil) every six
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hours for seven consecutive days. For pain control
buprenorphine (Temgesic 0.3mg ml-1 – Cloridrato de
Buprenorfina – Schering-Plough – Rio de Janeiro, RJ,
Brasil) was administered subcutaneously in the dosage
of 0.01mg kg-1 every 12 hours for five consecutive days.
The parameters concerning chemosis,
blepharospasm, conjunctival hyperemia, hemorrhage,
secretion and strabismus were evaluated for up to 120
days. Qualitative and quantitative criteria were
followed: absent (nihil), discrete (+), moderate (++) and
intense (+++).
Macroscopical, histological and
immunohistochemical evaluation of the myoplastic
areas were conducted for the postoperative periods of
15, 30, 60 and 120 days. For this purpose the animals
were again subjected to anesthesia following the
adopted protocol for the surgical procedures.
For adhesions evaluations as a quantity
criterion, nihil represents absence of adhesions, (+)
few adhesions, (++) moderate adhesions, (+++) many
adhesions. To evaluate its intensity the adhesions were
qualified from 0 to 4, where 0- absence of adhesions; 1-
Figure 1 - Photographic and photomicrographs images of mioplasties of dorsal rectus of laboratory albino
adult rabbits in different groups and periods. A - Transfixion of the muscle prior to recession. B
– Myoscleral suture of the rectus dorsal muscle (rd). C – 15 days- PCG: intense fibrosis (f)
between the muscle (m) and the sclera (e) (Tric, 60x). D – 30 days – PCG: moderate fibrosis
around the granuloma (g) and between the muscular fibers (m) (Tric, 60x). E – 15 days – NCG:
Moderate expression of FGF-2 in macrophages (black arrows) (Immunohistochemical, 150x). F
– 30 days – GT-1: moderate marking of FGF-2 in macrophages (black arrow) and in fibroblasts
(red arrow) (Immunohistochemical, 300x).
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limited adhesions easily separated by dissection. 2 –
mild to moderate adhesions; 3 – moderate to dense
adhesions with difficult dissection and 4 – strong
nondissectible adhesions.
For histopathological purposes, tissues
containing sclera and muscular portions were extracted
from the adjacent surgical areas. They were fixed for 24
hours in 10% buffered formalin and sectioned in paraffin.
Sections of 5μm were prepared and the laminas were
stained with hematoxylineosin and Masson’s
Trichrome. Thereafter, for scientific documentation
purposes, a photomicroscope was used to evaluate
the cells and events related to fibrosis. In addition,
immunohistochemical was used to demonstrate FGF-2.
 The quantified events were analysis
statistically using Kruskal-Wallis (one-way analysis of
variance for nonparametric data) with the level of
significance set at 5% (P=0.05).
RESULTS
The clinical evaluation of the operated eyes
showed chemosis only in the first days of the
postoperative follow up. Moderate levels of
blepharospasm were assessed on the first day of
evaluation only in the NCG animals. In the other groups
blepharospasm was absent or present in minimal levels.
Intense conjunctival hyperemia was observed up to
the fifth day of evaluation in the majority of the animals
of every group, tending to diminish in the subsequent
periods. Ocular hemorrhage was not observed during
the evaluation process. Secretion, when present, was
of the mucous type and appeared moderately in the
NCG animals. In the other groups the secretion, when
present, was even discrete. Statistical differences were
not observed (Figure 2).
Discrete to moderate hypotropia was
observed. At every moment of the evaluation the eyes
treated with mitomycin C, regardless its concentration,
showed adhesions in lesser significant quantities and
levels when compared to the control group of
myoplasties. However statistical difference was found
only between PCG and GT-3, at the 15th postoperative
day (P<0.01) (Figure 2).
In the early stages of the follow up, the
histological evaluation showed intense granulomatous
and lymphocytic inflammatory reaction at the mioplastic
areas. The granulomatous reaction occurred similarly
between the groups on the 15th, 30th and 60th
Postoperative. On the 120th day, half the animals of the
GT-2 group showed a delayed involution. Regarding
the fibrosis, on the 15th day a smaller incidence was
observed in the control groups when compared to
treated groups. However after 15 days it was observed
a tendency to an increase of fibrosis in the control
groups and a decrease in the groups treated with
mitomycin C. At the end of the evaluation (120 days)
the groups showed moderate and with no significant
differences (Figure 1).
Immunohistochemical evaluation showed
expression of the FGF-2 in fibroblasts and macrophages
in different grades and variables, according to the
periods of the evaluation. At 15 day it was observed
moderate to intense expressions in the animals of NCG
groups. In the other groups they varied from discrete
to moderate. At 30 day it was observed a great increase
in the FGF-2 expressions in all groups. In the NCG group
it evolved to an intense grade while in the other groups
it was maintained in moderate. After 60 days it was
observed a great decrease in the FGF-2 marking in every
group, evolving to a discrete on day 120th (Figure 1).
DISCUSSION
The clinical evaluation indicates that most
animals showed, at some moment of the postoperative,
signs of chemosis, blefarospasm, conjunctival
hyperemia and mucous ocular secretion. Chemosis was
present in the acute phases of the postoperative and
in a discrete form in every animal. Due to its pattern
and rapid development we believe it was caused by
surgical trauma. The conjunctival hyperemia, present
especially in the early days of evaluation, is also due
to the surgical procedures. The hyperemia was more
intense in the area around the suture as reported by
DADEYA & KAMLESH (2001). In general the qualified
and quantified clinical signs showed no differences
between the groups, allowing us to assume that
mitomycin C as applied in the intraoperative did not
induce exudation in the eyes surface, in opposition to
the findings of MAMEDE et al. (2004) when it was
utilized in the postoperative for 14 days.
Adhesions were present in all of
myoplasties. When we compared the NCG and PCG
groups no differences were seen. Those findings lead
us to assume that mitomycin C, according to the utilized
protocol, was not absorbed by systemic via in enough
quantity to produce any effect in the contra-lateral eyes.
The findings confirm those of MATTAR et al. (1995),
who inform that mitomycin C acts only in the applied
area.
When comparing the NCG and PCG groups
with the groups treated with mitomycin C (GT-1, GT-2,
GT-3) it was found in the controls a greater quantity
and grades of adhesion in all evaluated periods. Those
133Intraoperative topical administration of mitomycin C, in different concentrations, on the cicatrization of mioplasties...
Ciência Rural, v.38, n.1, jan-fev, 2008.
findings corroborate CRUZ & MATKOVICH (1995),
CRUZ (1996) OH et al. (1999) and MAHINDRAKAR et
al. (2001). However, despite the confirmation of these
facts, statistically there was no difference, except when
comparing the PCG and GT-3 on 15th postoperative.
Adhesions were present in a similar form in the groups
treated with mitomycin C in different concentrations.
Therefore it is assumed that the use of smaller
concentration has the same antifibrotic effect.
     Inflammatory reaction of the
granulamatous and lymphocytic type, as seen in the
early stages of the postoperative, was similar to the
findings of INGRAM (1965), who studied in rabbits
the effects caused by recess of the extrinsic muscle of
the eyes without the interference of any drugs.
Therefore it is fair to assume that the surgical procedure
and the suture material have caused this inflammatory
reaction.
The granuloma that was formed in the
myoplastic areas occurred in the same way between
the groups, in the evaluation periods of 15, 30 and 60
days. On the 120th day there was a delayed involution
Figure 2 - Graphics representations of the quantities of chemosis, blefarospasm, conjunctival hyperemia, secretion, adhesions
and intensity of adhesions of the groups Negative Control Group (NCG), Positive Control Group (PCG), GT-1,
GT-2 and GT-3, truth the evaluations.
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of the granuloma in 50% of the animals treated with
mitomycin C at 0.02% (GT-2). Fibrosis occurred more
intensively in the treated groups until 60 days.
Afterwards it was equivalent to the mitomycin C control
groups. Therefore we assume that mitomycin C may
have slowed the occurrence of fibrosis on the applied
area, which corroborate the results found by RIBEIRO
et al. (2003), who study the effects of mitomycin C in
rat’s derma.
Regarding the immunohistochemical, the
FGF-2 expressed for fibroblasts as well as for
macrophages confirms the findings of FUNATO et al.
(1999) and WANG et al. (2001). In the present research
the intensity of the expression of FGF-2 occurred in a
very similar way between the studied groups. Those
results oppose the findings of OH et al. (1999), which
reported a smaller expression in animals that received
mitomycin C. Since FGF-2 is produced by
macrophages, fibroblasts, mast cells, lymphocytes T
and by endothelial cells (KUMAR et al., 2005) and if
mitomycin C has effect only over fibroblastic
proliferation (YAMAMOTO et al., 1990), we admit that
it has little interference on the production of FGF-2.
CONCLUSIONS
Based on our investigation, it is possible to
admit that mitomycin C allows clinical occurrence of
smaller adhesions in the myoplastic areas, although
the result was not statistically significant. Under light
microscope study mitomycin C delayed the occurrence
of fibrosis formation in the myoplastic areas, especially
in the 0.02% concentrations. According to
immunohistochemical analyses, the FGF-2 suffered no
interference from mitomycin C effect in any moment of
the evaluation. The clinical evaluation showed no side
effects by using the mitomycin C.
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